Blomgren H, Wasserman J, Rotstein S, Petrini B, von Stedingk L V
Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.
Anticancer Res. 1988 Jul-Aug;8(4):839-44.
The objective of this investigation was to examine further the influence of postoperative adjuvant treatment with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on the immune system in breast cancer patients and to explore whether such changes are related to prognosis. The 12 CMF courses which were given for a period of 1 year resulted in a progressive lymphopenia. The relative spontaneous secretions of IgA and IgG in vitro increased 4- and 2-fold respectively after the first 3 courses, whereas IgM secretion was unaffected. IgA and IgG secretions in PWM stimulated cultures were not changed, whereas there was a sharp decrease of IgM. The CMF-induced changes of Ig-secretions were similar in patients who developed recurrent disease during a 4-6 year follow-up (n = 11) and those who remained clinically disease-free (n = 14). The results are discussed in relation to the immunopotentiation which may occur following treatment with relatively low doses of chemotherapeutic agents.
本研究的目的是进一步探讨环磷酰胺、甲氨蝶呤和5-氟尿嘧啶(CMF)术后辅助治疗对乳腺癌患者免疫系统的影响,并探究这些变化是否与预后相关。为期1年的12个疗程CMF治疗导致进行性淋巴细胞减少。前3个疗程后,体外IgA和IgG的相对自发分泌分别增加了4倍和2倍,而IgM分泌未受影响。PWM刺激培养物中的IgA和IgG分泌没有变化,而IgM则急剧下降。在4至6年随访期间出现复发疾病的患者(n = 11)和临床无病患者(n = 14)中,CMF诱导的Ig分泌变化相似。结合使用相对低剂量化疗药物治疗后可能发生的免疫增强作用对结果进行了讨论。